Literature DB >> 6428980

Hepatotoxicity to sodium valproate: a review.

P R Powell-Jackson, J M Tredger, R Williams.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6428980      PMCID: PMC1432377          DOI: 10.1136/gut.25.6.673

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  46 in total

1.  Methyldopa Hepatitis. A report of six cases and review of the literature.

Authors:  J S Rodman; D J Deutsch; S I Gutman
Journal:  Am J Med       Date:  1976-06       Impact factor: 4.965

2.  Valproic acid and fatal hepatitis.

Authors:  J F Donat; J A Bocchini; E Gonzalez; R N Schwendimann
Journal:  Neurology       Date:  1979-02       Impact factor: 9.910

3.  Acute hepatic failure associated with the use of sodium valproate.

Authors:  F J Suchy; W F Balistreri; J J Buchino; J M Sondheimer; S R Bates; G L Kearns; J D Stull; K E Bove
Journal:  N Engl J Med       Date:  1979-04-26       Impact factor: 91.245

4.  Side effects of sodium valproate.

Authors:  M H Bellmann; E M Ross
Journal:  Br Med J       Date:  1977-06-25

5.  Isoniazid hepatitis.

Authors:  W C Maddrey; J K Boitnott
Journal:  Ann Intern Med       Date:  1973-07       Impact factor: 25.391

6.  Controlled trial of sodium valproate in severe epilepsy.

Authors:  A Richens; S Ahmad
Journal:  Br Med J       Date:  1975-11-01

7.  Isoniazid-associated hepatitis in 114 patients.

Authors:  M Black; J R Mitchell; H J Zimmerman; K G Ishak; G R Epler
Journal:  Gastroenterology       Date:  1975-08       Impact factor: 22.682

8.  Production of the features of Reye's syndrome in rats with 4-pentenoic acid.

Authors:  A M Glasgow; H P Chase
Journal:  Pediatr Res       Date:  1975-03       Impact factor: 3.756

9.  Valproic acid in epilepsy: clinical and pharmacological effects.

Authors:  R H Mattson; J A Cramer; P D Williamson; R A Novelly
Journal:  Ann Neurol       Date:  1978-01       Impact factor: 10.422

Review 10.  Hypoglycin and hypoglycin-like compounds.

Authors:  R Bressler; C Corredor; K Brendel
Journal:  Pharmacol Rev       Date:  1969-06       Impact factor: 25.468

View more
  31 in total

Review 1.  Clinically significant drug interactions with cyclosporin. An update.

Authors:  C Campana; M B Regazzi; I Buggia; M Molinaro
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

Review 2.  Diagnosis and treatment of bipolar disorders in adults: a review of the evidence on pharmacologic treatments.

Authors:  Michael W Jann
Journal:  Am Health Drug Benefits       Date:  2014-12

3.  Valproic Acid and Hepatic Steatosis: A Possible Link? About a Case Report.

Authors:  Leila Mnif; Rim Sellami; Jawaher Masmoudi
Journal:  Psychopharmacol Bull       Date:  2016-08-15

4.  Jaundice and hepatorenal syndrome associated with cytosine arabinoside.

Authors:  D W Kirtley; M L Votaw; E Thomas
Journal:  J Natl Med Assoc       Date:  1990-03       Impact factor: 1.798

5.  Exaggerated cholestasis and hepatic fibrosis following simultaneous administration of chlorpromazine and sodium valproate.

Authors:  N Bach; S N Thung; F Schaffner; H Tobias
Journal:  Dig Dis Sci       Date:  1989-08       Impact factor: 3.199

Review 6.  Biochemical relationships between Reye's and Reye's-like metabolic and toxicological syndromes.

Authors:  J Osterloh; W Cunningham; A Dixon; D Combest
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jul-Aug

7.  Fulminant hepatic failure induced by lamotrigine.

Authors:  A J Makin; S Fitt; R Williams; J S Duncan
Journal:  BMJ       Date:  1995-07-29

8.  Diclofenac enhances proinflammatory cytokine-induced aquaporin-4 expression in cultured astrocyte.

Authors:  Hayato Asai; Hiroki Kakita; Mineyoshi Aoyama; Yoshiaki Nagaya; Shinji Saitoh; Kiyofumi Asai
Journal:  Cell Mol Neurobiol       Date:  2013-01-16       Impact factor: 5.046

Review 9.  Drug-induced cholestasis.

Authors:  H J Zimmerman; J H Lewis
Journal:  Med Toxicol       Date:  1987 Mar-Apr

Review 10.  Valproate-associated hepatotoxicity and its biochemical mechanisms.

Authors:  M J Eadie; W D Hooper; R G Dickinson
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Mar-Apr
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.